期刊文献+

HR+/HER2-老年乳腺癌患者临床病理特征及预后分析

Clinicopathological features and prognostic analysis of elderly patients with HR+/HER2-breast cancer
下载PDF
导出
摘要 目的:探讨激素受体阳性(hormone receptor-positive,HR+)/人表皮生长因子受体2阴性(human epidermal growth factor receptor-2 negative,HER2-)老年乳腺癌患者临床病理特征及预后相关情况,为临床治疗提供相关依据。方法:在监测、流行病学和结果(surveillance,epidemiology and end results,SEER)数据库中筛选出老年乳腺癌患者41972例,按照7∶3分成测试组和验证组,用Cox回归分析筛选出影响预后的相关因素并建立列线图,利用一致性指数(C-index)和ROC曲线及校准曲线评价模型的预测能力及一致性。结果:测试组与验证组的临床病理特征间差异无统计学意义(P>0.05)。Cox回归分析筛选出年龄、婚姻状况、种族、T分期、N分期、病理分级、手术、放疗、孕激素受体状态是60岁以上HR+/HER2-老年乳腺癌患者的独立影响因素(P<0.05)。测试组和验证组列线图的C-index为0.761和0.763,测试组1、3、5年的ROC曲线的AUC为0.810、0.791、0.784,验证组为0.811、0.799、0.793。结论:利用SEER数据库建立了HR+/HER2-老年乳腺癌患者预后模型,可为临床诊疗时提供更准确的参考依据。 Objective:To investigate the clinicopathological features and prognostic correlation of hormone receptor-positive(HR+)/human epidermal growth factor receptor-2 negative(HER2-)elderly patients with breast cancer,so as to provide relevant evidence for clinical treatment.Methods:A total of 41972 elderly patients with breast cancer were selected from the surveillance,epidemiology and end results(SEER)database and divided into test group and verification group according to 7∶3.Cox regression was used to screen out prognostic factors and establish a nomogram.C-index,ROC curve and calibration curve were used to evaluate the predictive power and consistency of the model.Results:There was no significant difference in clinicopathological features between test group and verification group(P>0.05).Cox regression analysis showed that age,marital status,race,T stage,N stage,tumor grade,surgery,radiotherapy and progesterone receptor status were independent influencing factors for HR+/HER2-breast cancer patients over 60 years old(P<0.05).The C-index of nomogram in test group and verification group were 0.761 and 0.763,and the AUC in test group were 0.810,0.791 and 0.784 at years 1,3 and 5,and those in verification group were 0.811,0.799 and 0.793.Conclusion:The prognostic model of elderly patients with HR+/HER2-breast cancer was established by using SEER database,which can provide a more accurate reference for clinical diagnosis and treatment.
作者 陈珊珊 唐红萍 姚美华 曹利华 孙赛赛 王慧 黄燕华 陈春美 CHEN Shanshan;TANG Hongping;YAO Meihua;CAO Lihua;SUN Saisai;WANG Hui;HUANG Yanhua;CHEN Chunmei(Department of Infection Management,Qidong Hospital Affiliated to Nantong University,Qidong People's Hospital,Qidong Liver Cancer Institute,Jiangsu 226200)
出处 《南通大学学报(医学版)》 2024年第5期423-427,共5页 Journal of Nantong University(Medical sciences)
基金 南通市卫生健康委员会课题(MSZ2022101)。
关键词 乳腺癌 激素受体阳性/人表皮生长因子受体2阴性 预测模型 监测、流行病学和结果数据库 老年人 breast cancer hormone receptor-positive/human epidermal growth factor receptor-2 negative prognostic model surveillance,epidemiology and end results database the elderly
  • 相关文献

参考文献4

二级参考文献27

  • 1陈万青,李霓,曹毛毛,任建松,石菊芳,陈宏达,李江,林春青,于欣阳,崔宏,代敏,赫捷.2013—2017年中国城市癌症早诊早治项目基线结果分析[J].中国肿瘤,2020,0(1):1-6. 被引量:110
  • 2朱亚东.乳腺癌术后无瘤生存率的影响因素及腋窝淋巴结检测数目的临床意义[J].实用癌症杂志,2014,29(2):222-225. 被引量:8
  • 3Tsunematsu M, Kakehashi M. An analysis of mass screening strategies using a mathematical model: comparison of breast cancer screening in Japan and the United States [ J ]. J Epidemi- ol, 2015, 25 (2): 162, 171.
  • 4Orit KP, Abraham K, Georgina Anastasia W, et al. Should ra- diotherapy be omitted in women age 70 years or older with early breast cancer [J]. J Clin Oneol, 2013, 31 (36) : 4569.
  • 5Katik S, Gort M, Jobsen JJ, et al. Factors influencing time be- tween surgery and radiotherapy: A population based study of breast cancer patients [ J]. Breast, 2015, 24 (4): 468- 475.
  • 6Lee CN, Wetsehler MH, Chang Y, et al. Measuring decision quality: psychometric evaluation of a new instrument for breast cancer chemotherapy [J]. Med Inform Decis Mak, 2014, 14:73.
  • 7Lips EH, Mulder L, Ronde JJ, et al. Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chem- otherapy response [J]. Breast Cancer Res Treat, 2013, 140 (1): 63-71.
  • 8Lairson DR, Parikh RC, Cormier JN, et al. Cost-Effective- ness of Chemotherapy for Breast Cancer and Age Effect in Older Women [J]. Value Health, 2015, 18 (8): 1070-1078.
  • 9Chiaki N, Yasuto N, Kenzo S, et al. Development of a pre- diction model for lymph node metastasis in luminal A subtype breast cancer: the possibility to omit sentinel lymph node biopsy [J]. Cancer Lett, 2014, 353 (1): 52-58.
  • 10Schipper R J, Moossdorff M, Nelemans PJ, et al. A Model to Predict Pathologic Complete Response of Axillary Lymph Nodes to Neoadjuvant Chemo (Immuno) Therapy in Patients With Clinically Node-Posltive Breast Cancer [ J ]. Clin Breast Canc- er, 2014, 14 (5): 315-322.

共引文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部